Dynamic Technology Lab Private Ltd Purchases Shares of 1,800 HCA Healthcare, Inc. (NYSE:HCA)

Dynamic Technology Lab Private Ltd bought a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 1,800 shares of the company's stock, valued at approximately $540,000.

A number of other large investors have also recently added to or reduced their stakes in the company. Congress Wealth Management LLC DE lifted its position in HCA Healthcare by 3.4% during the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock worth $312,000 after acquiring an additional 34 shares during the last quarter. Evergreen Private Wealth LLC raised its stake in HCA Healthcare by 0.3% in the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock valued at $3,838,000 after purchasing an additional 35 shares in the last quarter. Mediolanum International Funds Ltd lifted its holdings in shares of HCA Healthcare by 0.3% during the 4th quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company's stock worth $3,153,000 after acquiring an additional 36 shares during the period. Prairie Wealth Advisors Inc. raised its position in HCA Healthcare by 6.1% during the fourth quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company's stock valued at $210,000 after purchasing an additional 40 shares in the last quarter. Finally, Whittier Trust Co. raised its stake in HCA Healthcare by 3.6% during the fourth quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock worth $359,000 after acquiring an additional 41 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.30% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on HCA. Barclays dropped their price target on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a research note on Monday, January 27th. Cantor Fitzgerald reissued an "overweight" rating and set a $405.00 target price on shares of HCA Healthcare in a report on Monday, January 27th. KeyCorp reduced their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 7th. StockNews.com lowered HCA Healthcare from a "buy" rating to a "hold" rating in a research note on Wednesday. Finally, JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $380.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 17th. One analyst has rated the stock with a sell rating, five have issued a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $385.67.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock traded down $1.92 on Friday, hitting $333.07. 1,677,512 shares of the company traded hands, compared to its average volume of 1,391,060. The company has a market cap of $82.00 billion, a P/E ratio of 15.16, a P/E/G ratio of 1.10 and a beta of 1.48. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The firm's 50-day simple moving average is $327.53 and its 200 day simple moving average is $336.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the previous year, the business posted $5.90 EPS. Analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.86%. The ex-dividend date was Monday, March 17th. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. HCA Healthcare's dividend payout ratio (DPR) is presently 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.